US trials for St Jude's dual-chamber ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
St Jude Medical has begun US clinical trials for its Photon DR dual-chamber implantable cardioverter defibrillator (ICD). The 46cc device, which combines bradycardia capabilities with tachycardia therapy, has a thickness of 12.7mm and is the thinnest dual-chamber ICD yet, said the St Paul, Minnesota-based company. The Photon has already been implanted in patients in clinical trials in Germany (see Clinica No 891, p 18).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.